The goal of this study is to investigate the familial transmission of the spectrum of bipolar disorder in a nonclinical sample of probands with a broad range of manifestations of mood disorders. The sample included a total of 447 probands recruited from a clinically enriched community screening and their 2082 adult living and deceased first-degree relatives. A best estimate diagnostic procedure that was based on either direct semistructured interview or structured family history information from multiple informants regarding non-interviewed relatives was employed. Results revealed that there was specificity of familial aggregation of bipolar I (BP I; odds ratio (OR) ¼ 8.40; 3.27-20.97; h2 ¼ 0.83) and major depressive disorder (OR ¼ 2.26; 1.58-3.22; h2 ¼ 0.20), but not BP II. The familial aggregation of BP I was primarily attributable to the familial specificity of manic episodes after adjusting for both proband and relative comorbid anxiety and substance use disorders. There was no significant cross-aggregation between mood disorder subtypes suggesting that the familial transmission of manic and major depressive episodes is independent despite the high magnitude of comorbidity between these mood states. These findings confirm those of earlier studies of the familial aggregation of bipolar disorder and major depression in the first nonclinical sample, and the largest family study of bipolar disorder in the USA using contemporary nonhierarchical diagnostic criteria for mood and anxiety disorders. The results suggest that these major components of bipolar disorder may represent distinct underlying pathways rather than increasingly severe manifestations of a common underlying diathesis. Therefore, dissection of the broad bipolar phenotype in genetic studies could actually generate new findings that could index novel biologic pathways underlying bipolar disorder.
INTRODUCTION
The lack of rapid success of the application of advances in molecular genetics in identifying genes underlying bipolar disorder has been disappointing in light of the compelling evidence for the high heritability of this condition from controlled family studies [1] [2] [3] [4] and twin studies. [5] [6] [7] The slow progress and preliminary evidence for some common genetic variants across the diagnostic boundaries has led to renewed concern that the major impediment to progress may lie in the lack of validity of the current diagnostic classification systems. 8 However, most of the evidence regarding the role of genes in bipolar disorder was collected more than 25 years ago 1, 2, 5, 9 in clinical samples that may not reflect the full spectrum of mood disorder in the general population that is increasingly being included in genetic studies. 10 Application of the hierarchical diagnostic systems in these studies precluded simultaneous classification of schizophrenia and bipolar disorder, mood disorders and anxiety disorders 8, 11 or behavior disorders, particularly attention deficit hyperactivity disorder. 12 Moreover, only a few of these studies investigated the specificity of the familial aggregation of subtypes of bipolar disorder and their relationship to major depressive disorder (MDD), with inconclusive results. 1, 3 Comprehensive reviews of aggregate data from numerous sources 13 suggest that mania and depression may be etiologically distinct despite their high co-occurrence. Our finding that major depressive episodes (MDE) were no more strongly associated with manic episodes in mid-adolescence than with generalized anxiety disorder, posttraumatic stress disorder or eating disorders in a nationally representative US sample of adolescents 14 provided compelling rationale for distinguishing between mania and depression in our family study analyses.
The goal of the present study is to examine the familial links between manic and depressive episodes in the NIMH Family Study of Affective Spectrum Disorders, a community-based family study that evaluates the core features, diagnostic thresholds, subtypes and boundaries of mood disorders with other mental and physical disorders and their association with a comprehensive set of biologic measures as potential endophenotypes for mood disorders. 15 The major aims of this paper are:
1. To investigate the familial transmission of mood disorder subtypes (for example, bipolar I (BP I), BP II and MDD) and their association with anxiety disorders and substance use disorders. 2. To examine the specificity of manic, hypomanic and depressive episodes in probands and relatives. 1 
MATERIALS AND METHODS Sample
Probands. A total of 447 probands was recruited from a community screening of the greater Washington, DC metropolitan area (n ¼ 199), the National Institutes of Health (NIH) Clinical Center general volunteer referral core and local health newsletters and announcements (n ¼ 219) and from screens or participants in the NIMH Mood and Anxiety Disorder Program (n ¼ 29). The community sample was recruited through screening a sample of 11 000 households within 50 miles of Washington, DC with a letter followed by reminders by mail. Twenty percent of households that did not respond to any of the mailings were contacted by study recruiters to encourage their participation. Inclusion criteria were an ability to speak English, and availability and consent to contact at least two living firstdegree relatives.
Relatives. Seventy-three percent of the probands had at least one firstdegree adult relative with a diagnostic interview (n ¼ 559). The interviewed relatives represent 71% of the first-degree relatives who were alive and could be located, 73% of whom enrolled in the study. Family history information was systematically collected from probands and interviewed relatives regarding a total of 1523 living and deceased adult first-degree relatives, yielding a total of 2082 first-degree relatives for these analyses. Multiple family history reports were available for 36% of the relatives. There was an average of one adult sibling and offspring per proband. All analyses were controlled for interview status, and stratified models by interview status were also run to test the stability of the results for interviewed and non-interviewed relatives.
Procedures
Standard family study methodology was employed including direct interviews of probands and relatives by experienced clinicians, systematic enumeration of first-, second-and third-degree relatives including children and blind assessment of relatives. 16 The study was approved by the Combined Neuroscience IRB at the NIH. All subjects provided written informed consent.
Diagnostic assessments. The NIMH Family Study Diagnostic Interview for Affective Spectrum Disorders (DIAS) was based on the adaptation of the diagnostic interview used in our earlier family studies of anxiety disorders and substance use disorders at the Yale University School of Medicine Genetic Epidemiology Research Unit based on the SADS/DIGS. 17, 18 The DIAS ascertains diagnostic criteria for current and lifetime DSM-IV-TR disorders, but does not adhere to strict diagnostic criteria for skip-outs based on frequency or duration at the probe level in order to capture subthreshold phenomenology across the key domains of psychopathology for multiple diagnostic systems. 19, 20 Inter-rater reliability was excellent (intraclass coefficients exceeded 0.87 or above for all major diagnostic categories) and the DIAS detected all cases of mood disorders derived from structured clinical interview for DSM-IV interviews on the inpatient unit of the NIH Clinical Center. The NIMH Family Study Family History Interview (DIAS-FHX) was used to assess a family history of psychiatric disorders. The DIAS-FHX was based on modifications of the family history interview from our previous family study research. 17, 18, 21 The systematic inter-rater reliability of all diagnostic categories in the present study was very high with an intraclass correlation of 0.87 and above across all diagnostic categories.
Best estimate diagnoses for this study were based on all available information by a team of experienced clinicians (psychologists and a psychiatrist) using a best estimate procedure. 22 The current analyses assess BP I and II disorder subtypes and MDD as defined by DSM-IV, and then distinguish mania and hypomania episodes and major depressive episodes independent of the bipolar disorder subtype. Anxiety disorders include generalized anxiety disorder, panic disorder and social phobia. The sensitivity estimates of direct interview versus best estimate diagnoses that also included family history information were: 62% for BP I, 75% for BP II and 86% for MDD. This indicates the importance of family history information for the diagnosis of BP I.
Statistical methods
Mixed effects logistic regression, which includes both fixed and random effects, was used to evaluate the association between proband and relative mood disorders. A random intercept was included to test for the variability among family members in each family. Adjusted models included the key proband and relative mood episode subtype, sociodemographic factors including sex of the proband and sex and age of the relative, comorbid anxiety and substance use disorders in probands and relatives, and methodologic variables including source of proband recruitment (clinic versus community/other) and interview status of relative in models that included diagnoses of non-interviewed relatives obtained by the family history method because of the well-documented false negative rate. Analyses were completed using SAS 9.2 (SAS Institute, Cary, NC, USA).
The heritability of mania, hypomania and major depression episodes based on the threshold liability model of Falconer 23 was estimated using SOLAR software, San Antonio, TX, USA (Southwest Foundation for Biomedical Research). 24 Polygenic heritability estimates defined as the proportion of the total phenotypic variance explained by additive genetic (or familial) effects were calculated, adjusted for age and gender using the variance components approach implemented in the SOLAR package. 25 Information on the covariance among relatives was used to estimate the polygenic (or additive genetic) component of variance. 24 Table 1 presents the demographic and clinical characteristics of probands and relatives by proband mood disorder subtypes. Proband mood disorders are presented in mutually exclusive subgroups of the lifetime mood disorder subtypes. There were 62 probands with BP I, 66 with BP II, 162 with MDD and 157 with nonmood disorders (anxiety, eating and substance use disorders) or no disorder (controls). The average age of the probands was 49 years, with more females than males across the diagnostic groups. About 14% of those with BP I or BP II were identified in clinical settings compared with 5.6% of those with MDD and 1.9% with other disorders or no disorders. More than half of the probands had graduated from college. Consistent with comorbidity patterns in population-based samples, about 70% of the bipolar and 62% of the MDD probands met criteria for comorbid anxiety disorders, and nearly half of the bipolar probands met criteria for substance use disorders. Direct interviews were conducted with at least one Table 2 shows the lifetime prevalence rates of mood disorder subgroups by mutually exclusive subgroups of proband mood disorders and the adjusted odds ratios (ORs) derived from nonlinear mixed models of the associations between proband and relative mood disorder subtypes. The prevalence rates of mood disorders were elevated among relatives of probands with mood disorders compared with those of controls. The results of adjusted models revealed specificity of familial aggregation of the subtypes of mood disorders, particularly for BP I (OR ¼ 8. All of these models also controlled for proband sex and source that were not significantly associated with any of the outcomes, as well as relative sex, age and interview status. Interview status was strongly associated with all of the outcomes in these analyses. We also controlled for proband major depressive episodes in the mania aggregation analyses and manic episodes in the depressive episode aggregation analyses and the significance of the aggregation of mania and of depressive episodes remained significant. We also ran the analyses controlling for proband education and did not find significant effects in any of the models. Figure 1a shows the results of the analyses of the specificity of familial aggregation of mania, hypomania and major depressive episodes after controlling for demographic characteristics, comorbid disorders and interview status of relatives. There is a strong association between proband and relative mania (OR ¼ 8.27, 3.82-17.91) and a less potent but still significant familial association between major depression in probands and relatives (OR ¼ 2.45, 1.66-3.62). The heritability coefficients for the mood disorder subgroups that indicate the extent to which the variance is attributable to familiality are also shown in Figure 1a . All of these coefficients demonstrate familiality, but the heritability of mania was greatest with the very small P-value and narrow confidence intervals. Figure 1b presents the cross-aggregation of mania, hypomania and major depressive episodes in probands and relatives. There were no significant associations between pairs of proband and relative mood disorder subtypes, particularly MDE among relatives of probands with mania (OR ¼ 1.00) or between manic episodes among relatives and MDE in probands (OR ¼ 0.67).
RESULTS

DISCUSSION
These findings confirm earlier studies of the familial aggregation of bipolar disorder and major depression 1, 2, 9 in the first nonclinical sample, and the largest family study of bipolar disorder in the USA using contemporary nonhierarchical diagnostic criteria for mood and anxiety disorders. The most important finding is that mania and major depression are largely transmitted independently in families, suggesting that these major components of bipolar disorder may represent distinct underlying pathways rather than increasingly severe manifestations of a common underlying diathesis. This work has major implications for future genetic studies as well as relevance for classification, etiology and treatment of mood disorders.
With regard to the mood disorder subtypes, the eightfold association between manic episodes in probands and relatives that was highly specific and heritable suggests that the familial aggregation of bipolar disorder can be primarily attributed to mania. In fact, early descriptions of mania as a 'functional disturbance of brain with increased excitability' manifest by increased speed of all processes, did not even consider a mood change as a core feature. 26 By contrast, the lack of familial clustering of hypomania, the core feature of the BP II subtype, suggests that BP I and II disorders do not represent more manifestations of a common underlying liability with respectively more severe manifestations that had been demonstrated in early studies of bipolar disorder. 1, 2 In fact, the BP II subtype appears to be more closely aligned with major depression than with mania. These effects were not moderated by either proband anxiety disorders or substance use disorders, indicating their familial independence from mood disorders. Therefore, the requirement of major depression as a criterion for BP II but not for BP I in contemporary diagnostic nomenclature requires further investigation.
These findings highlight the importance of the distinction between mania and depression as separate disease processes in accordance with the conclusion of a recent comprehensive review of evidence that bipolar disorder comprises two distinct yet highly comorbid syndromes. 13 Evidence for this distinction is provided by different patterns of course, symptomatology, neurobiology and psychosocial risk factors. For example, manic and depressive episodes were associated with differential levels of disability and impairment in long-term follow-up studies of patients with mood disorders, such as the 15-and 20-year follow-ups of the NIMH Collaborative Study of Depression. [27] [28] [29] Likewise, there is compelling evidence for differential treatment strategies for BP I and II disorders. 30 The high comorbidity between mania and major depression could result from depression as a consequence of the excitatory processes associated with mania, 31 differences in the characteristics of depression associated with the underlying diathesis of mania and bipolarity from those that give rise to major depression without mania or a third factor that may influence the expression of both mania and depression such as anxiety or attentional disorders. 13 This work also illustrates the importance of cross-fertilization of research across clinical and community samples with a developmental perspective to provide a comprehensive portrait of manifestations of these conditions. The critical evidence that led us to distinguish between mania and depression emanated from a large population study that investigated patterns of mania and depression close to their onset in the developmental course. 14 With the strong association between manic and depressive episodes, it is not surprising that bipolar disorder appears to be a unitary diagnostic entity in the clinical samples that have been the basis for the establishment of diagnostic criteria in psychiatry. However, the general belief that unipolar mania is extremely rare, could actually be, in part, an artifact of clinical sampling. 32 This study has incorporated several features that advance our understanding of the familial nature of bipolar disorder. First, the recruitment of probands from predominantly nontreatment settings minimizes the growing bias that characterizes specialty treatment settings from which the bulk of family and genetic studies have recruited probands with bipolar disorder. The community sampling also provided a broad range of severity of mood and anxiety disorders as well as a representative sample of unaffected people to serve as controls. Second, the inclusion of people with a range of conditions enabled us to examine patterns of comorbidity that had only been available in a few prior studies that had directly recruited probands with the full range of mood and anxiety subtypes. Third, the diagnostic interview employed in this study captures the full range of phenomenology of mood and anxiety disorders without strict adherence to a particular diagnostic classification system to tap their core dimensional underpinnings and core components.
Limitations include the lack of generalizability to more severely affected persons with bipolar disorder with overlapping schizoaffective and/or severe psychosis who were only detected rarely in this community-based sample; the cross-sectional interviews that generally underestimate prevalence rates of mental disorders; and despite extensive efforts to obtain direct interviews with all enrolled relatives, there was still a substantial proportion about whom we had to rely on reports by family members. Another potential limitation is the lack of reliability of hypomania that has been a controversial subgroup particularly because of the requirement of a lack of impairment, which is a rather counterintuitive inclusion criterion for a psychiatric diagnostic category. Our reliance on multiple family histories to report hypomania, changes in activity as well as the traditional elevated or irritable mood changes as an index of hypomania, and a conservative approach to the diagnosis in the initial analyses was intended to reduce false-positive diagnosis of this condition. Finally, the independence of mania and depression may not apply to subgroups, such as the 'atypical' subtype of depression that may actually be a manifestation of the same underlying dimension as that of mania. Such subgroup analyses and follow-up of the sample are currently ongoing.
With familial aggregation as the primary source of evidence regarding the role of genetic factors in disease etiology, the results provide compelling evidence that mania and major depression should also be evaluated as distinct phenotypes in future genetic studies. Although a family study cannot provide presumptive evidence that the independence of etiology of mania and depression can be attributed to genetic factors, the heritability estimate of 0.83 for mania in the present study is remarkably similar to the 0.85 heritability of mania estimated in the Maudsley Twin Registry study by McGuffin et al. 6 If genes underlying mania are partially distinct from those for depression, current knowledge regarding the genetic pathways for bipolar disorder may reflect a missed opportunity to characterize the molecular basis of mania. For example, the definition of the phenotype in many of the samples included in the large collaborative genetic studies of bipolar disorder include the full spectrum of bipolar disorders (BP I, BP II and bipolar NOS) as affected cases. [33] [34] [35] The independence of mania and depression, as well as the lack of shared familial risk for the bipolar I and II subtypes, suggests that use of this broad phenotypic definition may mask potential genetic associations with the most heritable subgroup of mania that was identified in this study. In fact, the heritability of any bipolar disorder of 0.61 in our study was substantially lower than that of mania (0.83). Therefore, dissection of the broader bipolar phenotype in these studies could actually generate new findings that could index novel biologic pathways underlying this condition.
This study also illustrates the value of the family study approach (and its extension to twins) in the era of molecular genetics. Despite the long history of information provided by family studies regarding the genetic architecture of Mendelian diseases as well as the heterogeneity of complex diseases such as breast cancer and diabetes, the family study approach has largely been abandoned in psychiatry in favor of very large case-control studies of diagnosed patients from clinical samples or registries. Yet, family studies still have an essential role in identifying cross-generational transmission of phenotypes and genotypes. With their assumption of homogeneity of etiology within families, family and twin studies can be employed to identify the sources of disease heterogeneity because of the assumption of homogeneity of etiology within families, to investigate mechanisms for comorbidity and boundaries of disorders by distinguishing causal associations from common etiologic factors underlying comorbid disorders and to discriminate the core components of the phenotype, phenotypic covariates (for example, early age of onset) and/or traits or markers (that is, endophenotypes) 36 that may represent intermediate forms of expression of underlying genes and the broader disease phenotype. The latter approach has been widely adopted in the schizophrenia field as demonstrated by studies such as the Collaborative Study on the Genetics of Schizophrenia 37 that have identified neurocognitive and neurophysiologic domains that may have genetic underpinnings. However, until recently, there are few comparable efforts underway for affective disorders. 38 Family-based studies will be of particular relevance in distinguishing de novo from heritable structural variants as well as in interpreting results of the growing data from next generation sequencing efforts.
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